EMC Instytut Medyczny SA

Wroclaw 54-239

2 studies enrolling now · 16 studies all time

What they study most

Atopic Dermatitis, Cancer of the Prostate, Chronic Hepatitis C Infection, Chronic Rhinosinusitis, Colitis, Ulcerative, HIV Infection, Hepatitis B, Chronic, Hormone Sensitive Prostate Cancer, Hypertension, Influenza and Other Novel Respiratory Viruses, Insomnia Disorders, Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Studies at this site

• A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight — Recruiting now
• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
• A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) — Completed
• A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause — Completed
• Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension — Completed
• A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder — Completed
• A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection — Stopped early
• Strategic Timing of Antiretroviral Treatment — Completed
• TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis — Completed
• An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps — Completed
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors — Completed
• Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis — Completed
• A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps — Completed
• Respiratory Virus Outpatient Study (FLU 002 Plus) — Completed
• A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed